Polymeric Nanoparticle Compositions for Encapsulation and Sustained Release of Neuromodulators

Case ID:
C16591

JHU Ref #: C16591

Value Proposition

·      Protein delivery system with tunable, sustained release profile, high payload capacity, and bioactivity retention

·      Neurotoxin release profile of at least 120 days

·      Scalable and translational manufacturing process

Unmet Need

·      Neurotoxins are widely used in the aesthetic and therapeutic space. Among the 16 million minimally invasive plastic surgery procedures performed in 2018, injection of Botulinum Toxin Type A (Botox) accounted for over 50% (American Society of Plastic Surgeons) These substances are typically administered to patients via injection. Neuromodulators work by paralyzing muscle bodies and subsequently provide relief for migraine and, more commonly, are used to reduce signs of aging for facial aesthetics. However, the products currently on the market suffer from fast clearance from the inject site with only a 14-day maximally effective release period. This requires that the patient undergoes follow-up visits at least every 3 months. Thus, there is a need for a delivery mechanism that facilitates sustained release of the neurotoxin.


Technology Overview

·      Inventors at Johns Hopkins have a developed a poly electrolyte nanocomplex (PNC) capable of encapsulating one or more neuromodulators. Here, they have optimized the nanoparticle to form a neuromodulator-polyanion nanocomplex that maintains the protein package’s bioactivity and release rate, allowing for high encapsulation efficiency and larger loading capacity. This platform allows for long-term release of the neuromodulator, with a release duration ranging from 1 to 6 months, which expands the total duration of effect to between 6 and 9 months. Furthermore, the production process for these nanoparticles have been optimized to allow for scalable production and manufacturing.

 

Stage of Development

·      The inventors have developed a working prototype and currently undergoing animal testing.


Data Availability

·      N/A


Publication

·      N/A

Patent Information:
Title App Type Country Serial No. Patent No. File Date Issued Date Expire Date Patent Status
POLYMERIC NANOPARTICLE COMPOSITIONS FOR ENCAPSULATION AND SUSTAINED RELEASE OF NEUROMODULATORS PCT: Patent Cooperation Treaty Canada 3,201,108   11/30/2021     Pending
POLYMERIC NANOPARTICLE COMPOSITIONS FOR ENCAPSULATION AND SUSTAINED RELEASE OF NEUROMODULATORS PCT: Patent Cooperation Treaty China 202180092717.1   11/30/2021     Pending
POLYMERIC NANOPARTICLE COMPOSITIONS FOR ENCAPSULATION AND SUSTAINED RELEASE OF NEUROMODULATORS PCT: Patent Cooperation Treaty European Patent Office 21901320.8   11/30/2021     Pending
POLYMERIC NANOPARTICLE COMPOSITIONS FOR ENCAPSULATION AND SUSTAINED RELEASE OF NEUROMODULATORS PCT: Patent Cooperation Treaty Singapore 11202304313S   11/30/2021     Pending
POLYMERIC NANOPARTICLE COMPOSITIONS FOR ENCAPSULATION AND SUSTAINED RELEASE OF NEUROMODULATORS PCT: Patent Cooperation Treaty United States 18/255,769   6/2/2023     Pending
Inventors:
Category(s):
Get custom alerts for techs in these categories/from these inventors:
For Information, Contact:
Lisa Schwier
lschwie2@jhu.edu
410-614-0300
Save This Technology:
2017 - 2022 © Johns Hopkins Technology Ventures. All Rights Reserved. Powered by Inteum